Ca. Dietl et al., RESULTS OF CORONARY-ARTERY BYPASS-GRAFTING USING MULTIPLE ARTERIAL CONDUITS, Journal of Cardiovascular Surgery, 34(6), 1993, pp. 513-516
Between January 1991 and June 1993, a total of 128 patients underwent
coronary artery bypass grafting employing multiple autologous arterial
conduits, including 157 internal mammary arteries, 69 inferior epigas
tric arteries, 44 gastroepiploic arteries, and 72 radial artery grafts
. Their mean age was 61.4 years (range 29 to 82 years). The patients w
ere divided into 2 groups: group A, consisted of 63 patients (mean age
60.3 years), in whom multiple arterial conduits were used exclusively
(no vein grafts); group, included 53 patients (mean age 62.7 years) i
n whom, in addition to multiple arterial conduits, 89 saphenous vein g
rafts were used concomitantly. The mean number of grafts was 3.1 and 3
.7, for groups A and B, respectively. The preoperative leftventricular
function, and the prevalence of unstable angina, a recent myocardial
infarction, and diabetes, were not significantly different between bot
h groups. Our series included 11 ''redo'' operations (8 in group A, an
d; 3 in group B). There were 6 early deaths (4.7% mortality) (1 in gro
up A, and 5 in group B), and 4 perioperative myocardial infarctions (1
in group A, 3 in group B). During a mean follow-up of 12.3 months (ra
nge 1 to 28 months) there were no late deaths or reoperations in any g
roup. All patients in group A are free of symptoms. In group B, 2 pati
ents have recurrent angina, and 1 had a late myocardial infarction, in
the distribution of a vein graft. A myocardial SPECT scan with exerci
se revealed new perfusion defects in 4 of 49 patients (1 in group A, 3
in group B), studied 1 year after surgery. In summary, multiple arter
ial conduits can be used safely for coronary bypass surgery, and ''red
o'' operations, with no increased surgical risk, and excellent results
after 2 years. A long-term follow-up will be necessary to determine i
f a complete myocardial revascularization without vein grafts will eff
ectively decrease the incidence of recurrent symptoms, late events, or
the heed for reoperation.